7. Accurate Prostate Cancer Biomarkers May Result in Highly Specific Urine Test
Researchers have identified that RNA markers in prostate biopsy samples and in the urine of prostate cancer patients are highly specific biomarkers for prostate cancer. The study, presented at the European Association of Urology Congress, is part of the research program RIBOLUTION (RIBOnucleic acid-based diagnostic soLUTIONs), an interdisciplinary consortium funded by the Fraunhofer Future Foundation, which aims to identify new RNA biomarkers for the development of novel diagnostic tests.